Hirsch FR - Search Results

1

Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status.

Goss G, Ferry D, Wierzbicki R, Laurie SA, Thompson J, Biesma B, Hirsch FR, Varella-Garcia M, Duffield E, Ataman OU, Zarenda M, Armour AA. Goss G, et al. Among authors: hirsch fr. J Clin Oncol. 2009 May 1;27(13):2253-60. doi: 10.1200/JCO.2008.18.4408. Epub 2009 Mar 16. J Clin Oncol. 2009. PMID: 19289623 Free PMC article. Clinical Trial.

2

Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.

Osterlind K, Hansen M, Hirsch FR, Dombernowsky P, Sörenson S, Pedersen AG, Hansen HH. Osterlind K, et al. Among authors: hirsch fr. Ann Oncol. 1991 Jan;2(1):41-6. doi: 10.1093/oxfordjournals.annonc.a057823. Ann Oncol. 1991. PMID: 1848996 Free article. Clinical Trial.

3

The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients.

Hirsch FR, Hansen HH, Hansen M, Osterlind K, Vindeløv LL, Dombernowsky P, Sørensson S. Hirsch FR, et al. J Clin Oncol. 1987 Apr;5(4):585-91. doi: 10.1200/JCO.1987.5.4.585. J Clin Oncol. 1987. PMID: 3031225 Clinical Trial.

4

Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.

Lassen U, Kristjansen PE, Osterlind K, Bergman B, Sigsgaard TC, Hirsch FR, Hansen M, Dombernowsky P, Hansen HH. Lassen U, et al. Among authors: hirsch fr. Ann Oncol. 1996 Apr;7(4):365-71. doi: 10.1093/oxfordjournals.annonc.a010603. Ann Oncol. 1996. PMID: 8805928 Free article. Clinical Trial.

5

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

Neijt JP, Engelholm SA, Tuxen MK, Sorensen PG, Hansen M, Sessa C, de Swart CA, Hirsch FR, Lund B, van Houwelingen HC. Neijt JP, et al. Among authors: hirsch fr. J Clin Oncol. 2000 Sep;18(17):3084-92. doi: 10.1200/JCO.2000.18.17.3084. J Clin Oncol. 2000. PMID: 10963636 Clinical Trial.

6

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.

Hirsch FR, Osterlind K, Jeppesen N, Dombernowsky P, Ingeberg S, Sorensen PG, Kristensen C, Hansen HH. Hirsch FR, et al. Ann Oncol. 2001 May;12(5):647-53. doi: 10.1023/a:1011132014518. Ann Oncol. 2001. PMID: 11432623 Free article. Clinical Trial.

7

Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.

Bunn PA Jr, Helfrich B, Soriano AF, Franklin WA, Varella-Garcia M, Hirsch FR, Baron A, Zeng C, Chan DC. Bunn PA Jr, et al. Among authors: hirsch fr. Clin Cancer Res. 2001 Oct;7(10):3239-50. Clin Cancer Res. 2001. PMID: 11595720

8

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.

Hirsch FR, Varella-Garcia M, Franklin WA, Veve R, Chen L, Helfrich B, Zeng C, Baron A, Bunn PA Jr. Hirsch FR, et al. Br J Cancer. 2002 May 6;86(9):1449-56. doi: 10.1038/sj.bjc.6600286. Br J Cancer. 2002. PMID: 11986780 Free PMC article.

9

High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, Gemmill RM, Drabkin HA, Franklin WA. Bremnes RM, et al. Among authors: hirsch fr. J Clin Oncol. 2002 May 15;20(10):2417-28. doi: 10.1200/JCO.2002.08.159. J Clin Oncol. 2002. PMID: 12011119

10

Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancer.

Hirsch FR, Witta S. Hirsch FR, et al. Curr Opin Oncol. 2005 Mar;17(2):118-22. doi: 10.1097/01.cco.0000155059.39733.9d. Curr Opin Oncol. 2005. PMID: 15725915 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters